Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2009
12/10/2009WO2009148958A1 Biomarker for assessing response to chymase treatment
12/10/2009WO2009148896A2 Anti-phospho-akt antibodies
12/10/2009WO2009148549A2 Novel biosensors for live cell imaging of intracellular proteins
12/10/2009WO2009148330A1 Compositions and methods for improving plants
12/10/2009WO2009147984A1 Dna encoding polypeptide involved in biosynthesis of herboxidiene
12/10/2009WO2009147549A1 Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging
12/10/2009WO2009147384A2 Peptide
12/10/2009WO2009147368A1 Peptides
12/10/2009WO2009147201A2 Anti-inflammatory agents
12/10/2009WO2009147196A1 Hiv-rev-multimerization inhibiting nanobodies
12/10/2009WO2009147180A2 Microbicidal peptides of trichoderma reesei
12/10/2009WO2009147060A1 Method for purifying erythropoietin
12/10/2009WO2009146902A1 A vaccine for the prevention and therapy of hcv infections
12/10/2009WO2009146886A2 Novel antibacterial peptides
12/10/2009WO2009146867A1 Pestivirus replicons providing an rna-based viral vector system
12/10/2009WO2009146803A1 Fully synthetic albumin analogue
12/10/2009WO2009146755A1 Polypeptide
12/10/2009WO2009129162A3 Methods and compositions for increasing plant disease resistance and yield
12/10/2009WO2009128951A3 Compositions of respiratory synctial virus proteins and methods of use
12/10/2009WO2009126896A3 Methods and compositions for root knot nematode control
12/10/2009WO2009126688A3 Novel compositions and methods for the treatment of immune related diseases
12/10/2009WO2009117640A3 Antibodies against interleukin-10 like cytokines and uses therefor
12/10/2009WO2009115509A3 Antigenic protein fragments of streptococcus pneumoniae
12/10/2009WO2009112301A3 Polypeptide agents in the form of conjugates of keratin-binding polypeptides, polymers, and effector molecules, method for the production thereof, and use thereof
12/10/2009WO2009109860A3 Mutant forms of chlamydia htra
12/10/2009WO2009103838A8 Detection and quantification of cyclic imines, based on competitive binding to nicotinic acetylcholine receptors
12/10/2009WO2009094172A3 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
12/10/2009WO2009077857A3 Trail variants for treating cancer
12/10/2009WO2009058285A3 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF
12/10/2009US20090307802 EPSPS Mutants
12/10/2009US20090307795 Zmtcrr-1 plant signal transduction gene and promoter
12/10/2009US20090307794 Stress-Induced Transcription Factor Derived from Maize
12/10/2009US20090307791 Calcium-activated chloride channel and methods of use thereof
12/10/2009US20090307789 Transgenic mollusk and method for producing the same
12/10/2009US20090306572 New Polypeptides, uses thereof and methods employing it
12/10/2009US20090306350 New purification method of lactoferrin
12/10/2009US20090306344 a polypeptide with mutation in at least one specific amino acid capable of potentiating C1-INH protection against complement activity; esterage enzyme inhibitor; gastrointestinal disorders
12/10/2009US20090306338 Stabilized GLP-1 Analogs
12/10/2009US20090306337 Pegylated, Extended Insulins
12/10/2009US20090306195 Fusion Proteins of Mycobacterium Tuberculosis
12/10/2009US20090306193 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
12/10/2009US20090306192 BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death
12/10/2009US20090306131 Cell lines with latent immunodeficiency virus and methods of use thereof
12/10/2009US20090306030 Methods Of Inhibiting Osteoclast Activity
12/10/2009US20090305998 Hsp90 inhibitors
12/10/2009US20090305992 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
12/10/2009US20090305991 33 Human Secreted Proteins
12/10/2009US20090305988 Modified peptide of human acidic fibroblast growth factor
12/10/2009US20090305986 FGF21 Mutants and uses thereof
12/10/2009US20090305985 Immunomodulatory Agents For Treatment of Inflammatory Diseases
12/10/2009US20090305984 Engineered CXCL 12 alpha locked dimer polypeptide
12/10/2009US20090305982 Muteins of tear lipocalin and methods for obtaining the same
12/10/2009US20090305981 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers
12/10/2009US20090305979 Compositions comprising hpv polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer
12/10/2009US20090305975 Use of Trap Protein Per se as an Active Ingredient for the Manufacture of a Medicament for the Treatment of Staphylococcus Aureus Infection
12/10/2009US20090305973 Novel peptide and use thereof
12/10/2009US20090305972 Novel cancer-associated antigen
12/10/2009US20090305971 Nogo-B Receptor
12/10/2009US20090305970 Toxin-Like Polypeptides, Polynucleotides Encoding Same and Uses Thereof
12/10/2009US20090305968 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
12/10/2009US20090305966 Use of histones for therapeutic purposes
12/10/2009US20090305962 Low density lipoprotein receptor fusion for use in prevention and treatment of inflammation and autoimmune diseases
12/10/2009US20090305961 Novel chimeric plasminogen activators and their pharmaceutical use
12/10/2009US20090305952 Anionic polyamide functionalized with a tryptophan unit
12/10/2009US20090305951 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells
12/10/2009US20090305950 Multimer of extracellular domain of cell surface functional molecule
12/10/2009US20090305949 Glycosylated specificity exchanger
12/10/2009US20090305946 presenilin/G-protein/c-src binding polypeptides ; modulate the physiologic interactions of polypeptides required for the production of beta -amyloid (A beta )
12/10/2009US20090305904 Apoptosis modulator bcl-b and methods for making and using same
12/10/2009US20090305434 Method of diagnosing neurophsychiatric diseases, eating disorders or metabolic diseases
12/10/2009US20090305433 Water-Soluble Rhodamine Dye Conjugates
12/10/2009US20090305419 Compositions for linking DNA-binding domains and cleavage domains
12/10/2009US20090305400 Modified chaperonin 10
12/10/2009US20090305398 Recombinant Double-Stranded RNA Phage, and Use of the Same
12/10/2009US20090305352 Activated collagen scaffold materials and their special fused active restoration factors
12/10/2009US20090305350 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides
12/10/2009US20090305346 Engineered cleavage half-domains
12/10/2009US20090305344 Chimeric alphavirus replicon particles
12/10/2009US20090305342 Solubilization and Purification of a Target Protein fused to a Mutant Maltose-Binding Protein
12/10/2009US20090305341 HCL-K1 Polypeptide Which Offers Collectin Activity
12/10/2009US20090305298 Binder for C-Reactive Protein
12/10/2009US20090305289 Screening method to identify protective substances for the treatment of neurodegenerative and/or ischaemic diseases
12/10/2009US20090305275 DNAs AND PROTEINS OR PEPTIDES SPECIFIC TO BACTERIA OF THE SPECIES NEISSERIA MENINGITIDIS, PROCESS FOR OBTAINING THEM AND THEIR BIOLOGICAL USES
12/10/2009US20090305270 Antigenic surface structure of sperm cells associated with the y chromosome
12/10/2009US20090305241 DNA demethylases and uses thereof
12/10/2009US20090304901 Modulating plant protein levels
12/10/2009US20090304858 Phosphoadenylyl Sulfate Reductase Gene and Use Thereof
12/10/2009US20090304817 Glycosylation Variants of Ricin-Like Proteins
12/10/2009US20090304814 Fibrillation resistant proteins
12/10/2009US20090304809 Dental fillers, methods, compositions including a caseinate
12/10/2009US20090304752 Hypoallergenic variants of the major allergen from betula verrucosa pollen
12/10/2009US20090304746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions
12/10/2009US20090304745 Chimeric alphavirus replicon particles
12/10/2009US20090304740 Use in HIV vaccines; HIV envelope proteins modified to expose the CD4 binding region
12/10/2009US20090304736 Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera
12/10/2009US20090304734 Immunogens for meningitidis-a vaccines
12/10/2009US20090304733 Vaccine comprising recombinant ct or lt toxin
12/10/2009US20090304732 Cryptosporidium Hominis Genes and Gene Products for Chemotherapeutic, Immunoprophylactic and Diagnostic Applications
12/10/2009US20090304731 Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae
12/10/2009US20090304728 Tem8 gene, expression forms and diagnostic and therapeutic uses thereof